What Our Endocrinologist Says Clinical experience shows that patient education and gradual dose titration prevent most discontinuations due to side effects
Recently, there has been concern about the potential link between NAION and the use of certain weight loss medications, including Ozempic and other semaglutide injectables like those mentioned above
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
The most frequently reported side effects are gastrointestinal symptoms such as nausea, vomiting, and diarrhoea, though some patients do report tiredness which may be related to various factors including dietary changes or blood glucose fluctuations
In summary, consulting with a healthcare professional while on Semaglutide is essential
